Factor VIII prophylactic therapy reduces neurological complications in patients with Hemophilia A
Authors:
- José Marcelino Aragão FernandesJFJosé Marcelino Aragão Fernandes
- Francisco de Assis Aquino GondimFGFrancisco de Assis Aquino Gondim
- Antônia Maria Negreiro DiasADAntônia Maria Negreiro Dias
- Rosângela de Albuquerque RibeiroRRRosângela de Albuquerque Ribeiro
- Luiz Ivando Pires Ferreira FilhoLFLuiz Ivando Pires Ferreira Filho
- Vicente de Paulo Teixeira PintoVPVicente de Paulo Teixeira Pinto
Open Access
- 1 December 2021
- journal article
- research article
- Published by FapUNIFESP (SciELO) in Arquivos de Neuro-Psiquiatria
- Vol. 79 (12) , 1116-1122
Abstract
Background: Bleeding in hemophiliacs can cause complications in the central and peripheral nervous system (CNS and PNS). The incidence of intracranial hemorrhage has reduced after the introduction of prophylactic treatment with factor VIII or IX, but the benefits of this therapy have not yet been evaluated on PNS complications. Objective: The aim of this study was to determine the prevalence of neurological complications in hemophiliacs and verify the effect of prophylactic therapy in these patients, including PNS disorders. Methods: We retrospectively evaluated the prevalence of CNS and PNS disorders caused by bleeding in hemophiliacs seen at the Hemocentro Regional Norte, Ceará, Brazil, from 1992 to 2018, and we compared the incidence in different periods (before and after the introduction of prophylactic treatment in 2011). Results: Of 75 hemophilia A patients evaluated (4.61/100.000 population), 13.3% (n=10) had either CNS (n=5) or PNS (n=5) disorders secondary to bleeding. Patients submitted to factor VIII replacement prophylactic therapy were less likely to have CNS events: from 1992 to 2011, 5 of 63 patients had CNS disease, while from 2011 to 2018, there were no new cases (p=0.0181). From 2011 to 2018, 5 PNS events occurred in patients without prophylactic therapy, whereas none occurred in those covered by prophylactic therapy (5/20 versus 0/29, p=0.0081). Conclusions: The prevalence of neurological complications in hemophiliacs in our cohort is similar to other studies. Similar to CNS, prophylactic therapy also reduces the risk of PNS complications. This is the first report in the literature showing this benefit.Keywords
This publication has 27 references indexed in Scilit:
- Intracranial haemorrhage in the Italian population of haemophilia patients with and without inhibitorsHaemophilia, 2011
- Associations between intracranial haemorrhage and prescribed prophylaxis in a large cohort of haemophilia patients in the United StatesBritish Journal of Haematology, 2010
- Long‐term consequences of intracranial haemorrhage in children with haemophiliaHaemophilia, 2009
- Intracranial haemorrhages in French haemophilia patients (1991–2001): clinical presentation, management and prognosis factors for deathHaemophilia, 2005
- Iliopsoas haemorrhage in patients with haemophilia: results from one centreHaemophilia, 2005
- Changes in the occurrence of and risk factors for hemophilia‐associated intracranial hemorrhageAmerican Journal of Hematology, 2001
- Prevalence and incidence of intracranial haemorrhage in a population of children with haemophiliaHaemophilia, 1999
- Peripheral nerve lesions in haemophiliaJournal of Neurology, 1981
- NEUROLOGICAL COMPLICATIONS IN HEMOPHILIAActa Paediatrica, 1981
- Haemophilic neuromyopathy.Journal of Neurology, Neurosurgery & Psychiatry, 1979